Vogelstein and colleagues' [52] research suggest that cancer mismatch repair errors can selectively up-regulate immunosuppression checkpoints such PD-1/PD-L1, CTLA-4, and IDO, resulting in local immunosuppression and TNA aggregation. This evidence concerns the gene CTLA4 and cancer.